Skip to main content
. Author manuscript; available in PMC: 2013 Nov 3.
Published in final edited form as: Behav Pharmacol. 2010 Dec;21(8):745–753. doi: 10.1097/FBP.0b013e32833fa7b3

Figure 1.

Figure 1

Dose-response functions for number of capsules earned on the progressive-ratio procedure, along with subjective ratings of Any Effect, Active-Alert-Energetic, Good Effects, Like Drug, Willing to Pay For and Stimulated from the Drug-Effect Questionnaire. Data are expresses as area-under-the-time-action curve (AUC). Horizontal axes: d-amphetamine dose in mg; data points above PL designate placebo values. Data points show means of 8 subjects; brackets show ± 1 S.E.M. Unidirectional brackets used in some instances for clarity. Filled symbols indicate those values that are significantly different from the placebo data point (p < 0.05, Fisher’s Protected Least Significant Difference post hoc test)